357 related articles for article (PubMed ID: 24001450)
41. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
[TBL] [Abstract][Full Text] [Related]
42. Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice.
Oda M; Koyanagi S; Tsurudome Y; Kanemitsu T; Matsunaga N; Ohdo S
Mol Pharmacol; 2014 May; 85(5):715-22. PubMed ID: 24567546
[TBL] [Abstract][Full Text] [Related]
43. MATE1 expression in the cochlea and its potential involvement in cisplatin cellular uptake and ototoxicity.
Waissbluth S; Martínez AD; Figueroa-Cares C; Sánchez HA; Maass JC
Acta Otolaryngol; 2023 Mar; 143(3):242-249. PubMed ID: 36943799
[TBL] [Abstract][Full Text] [Related]
44. Tamsulosin alters the pharmacokinetics of metformin via inhibition of renal multidrug and toxin extrusion protein 1 and organic cation transporter 2 in rats.
Saad AAA; Zhang F; Refat M; Mohammed EAH; Zhang M; Chen Y; Al Hamyari B; Alafifi J; Wu X
J Pharm Biomed Anal; 2022 Apr; 212():114666. PubMed ID: 35183887
[TBL] [Abstract][Full Text] [Related]
45. Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics.
Staud F; Cerveny L; Ahmadimoghaddam D; Ceckova M
Int J Biochem Cell Biol; 2013 Sep; 45(9):2007-11. PubMed ID: 23831838
[TBL] [Abstract][Full Text] [Related]
46. Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.
Müller F; Weitz D; Mertsch K; König J; Fromm MF
Mol Pharm; 2018 Aug; 15(8):3425-3433. PubMed ID: 29975542
[TBL] [Abstract][Full Text] [Related]
47. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.
Stocker SL; Morrissey KM; Yee SW; Castro RA; Xu L; Dahlin A; Ramirez AH; Roden DM; Wilke RA; McCarty CA; Davis RL; Brett CM; Giacomini KM
Clin Pharmacol Ther; 2013 Feb; 93(2):186-94. PubMed ID: 23267855
[TBL] [Abstract][Full Text] [Related]
48. Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.
Wongwan T; Chatsudthipong V; Soodvilai S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846898
[TBL] [Abstract][Full Text] [Related]
49. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
[TBL] [Abstract][Full Text] [Related]
50. Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.
Yonezawa A; Inui K
Br J Pharmacol; 2011 Dec; 164(7):1817-25. PubMed ID: 21457222
[TBL] [Abstract][Full Text] [Related]
51. Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families.
Chen J; Brockmöller J; Seitz T; König J; Chen X; Tzvetkov MV
Biol Chem; 2017 Feb; 398(2):237-249. PubMed ID: 27676604
[TBL] [Abstract][Full Text] [Related]
52. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.
Filipski KK; Mathijssen RH; Mikkelsen TS; Schinkel AH; Sparreboom A
Clin Pharmacol Ther; 2009 Oct; 86(4):396-402. PubMed ID: 19625999
[TBL] [Abstract][Full Text] [Related]
53. Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters.
Kajiwara M; Masuda S; Watanabe S; Terada T; Katsura T; Inui K
Drug Metab Pharmacokinet; 2012; 27(6):563-9. PubMed ID: 22510868
[TBL] [Abstract][Full Text] [Related]
54. The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment.
Cho SK; Chung JY
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):253-62. PubMed ID: 26784938
[TBL] [Abstract][Full Text] [Related]
55. A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators.
Yang Y; Zhang Z; Li P; Kong W; Liu X; Liu L
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064886
[TBL] [Abstract][Full Text] [Related]
56. Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters.
Martinez-Guerrero L; Zhang X; Zorn KM; Ekins S; Wright SH
J Pharmacol Exp Ther; 2021 Oct; 379(1):96-107. PubMed ID: 34253645
[TBL] [Abstract][Full Text] [Related]
57. Identification and characterization of an endogenous biomarker of the renal vectorial transport (OCT2-MATE1).
Ma Y; Wang X; Gou X; Wu X
Biopharm Drug Dispos; 2024 Feb; 45(1):43-57. PubMed ID: 38305087
[TBL] [Abstract][Full Text] [Related]
58. Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO).
Gessner A; König J; Fromm MF
Sci Rep; 2018 Apr; 8(1):6659. PubMed ID: 29704007
[TBL] [Abstract][Full Text] [Related]
59. Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.
Müller F; König J; Glaeser H; Schmidt I; Zolk O; Fromm MF; Maas R
Antimicrob Agents Chemother; 2011 Jul; 55(7):3091-8. PubMed ID: 21518836
[TBL] [Abstract][Full Text] [Related]
60. Mirogabalin, a novel α
Yamamura N; Mikkaichi T; Itokawa KI; Hoshi M; Damme K; Geigner S; Baumhauer C
Xenobiotica; 2022; 52(9-11):997-1009. PubMed ID: 36170033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
